| 1 | PERSONALIZED (LOCAL) UV-CROSSLINKING AS A TREATMENT OF KERAT… (10.18008/1816-5095-2017-3-195-199) | Abstract References ORCID License | 107.92 | 11 |
| 2 | MODERN METHODS OF CONTROLLING WOUND HEALING AFTER FISTULI… (10.18008/1816-5095-2017-2-99-105) | Abstract References ORCID License | 104.14 | 10 |
| 3 | Dry Eye Epidemiology in Patients before Refractive Operation… (10.18008/1816-5095-2018-1-92-101) | Abstract References ORCID License | 104.14 | 10 |
| 4 | CORNEAL GRAFT REJECTION AFTER KERATOPLASTY (10.18008/1816-5095-2017-3-180-187) | Abstract References ORCID License | 100.00 | 9 |
| 5 | To the Question of School Myopia (10.18008/1816-5095-2018-1-87-91) | Abstract References ORCID License | 100.00 | 9 |
| 6 | MICRO DIATHERMOCOAGULATION IN THE TREATMENT OF INFECTIOUS CO… (10.18008/1816-5095-2016-3-157-162) | Abstract References ORCID License | 95.42 | 8 |
| 7 | Modern Aspects of the Treatment of Acute Bacterial Postopera… (10.18008/1816-5095-2017-1-12-17) | Abstract References ORCID License | 95.42 | 8 |
| 8 | Тherapy Results in Patients with Primary Open Angle Glaucoma… (10.18008/1816-5095-2017-1-40-46) | Abstract References ORCID License | 95.42 | 8 |
| 9 | Long-term Results of Treatment of Patients with Non-prolifer… (10.18008/1816-5095-2017-1-67-77) | Abstract References ORCID License | 95.42 | 8 |
| 10 | МODIFIED CROSS-LINKING IN THE TRЕATMENT OF ADVANCED PURULENT… (10.18008/1816-5095-2017-3-274-277) | Abstract References ORCID License | 95.42 | 8 |
| 11 | General and Ophthalmic Manifestations of Herpes Virus Infect… (10.18008/1816-5095-2016-4-228-234) | Abstract References ORCID License | 90.31 | 7 |
| 12 | Comparative Evaluation of the Different Assessment Methods o… (10.18008/1816-5095-2016-4-265-272) | Abstract References ORCID License | 90.31 | 7 |
| 13 | MODERN TRENDS IN THE TREATMENT OF KERATOKONUS IN CHILDREN (10.18008/1816-5095-2017-3-188-194) | Abstract References ORCID License | 90.31 | 7 |
| 14 | NONINVASIVE METHODS ASSESSMENT BLOOD FLOW IN ANTERIOR SEGMEN… (10.18008/1816-5095-2017-4-283-290) | Abstract References License | 85.96 | 13 |
| 15 | THE EXPERIENCE OF TREGALOZA BASED LUBRICANT USAGE FOR PATIEN… (10.18008/1816-5095-2016-3-213-218) | Abstract References ORCID License | 84.51 | 6 |
| 16 | Methods of Screening for Meibomian Gland Dysfunction (10.18008/1816-5095-2016-4-235-240) | Abstract References ORCID License | 84.51 | 6 |
| 17 | Modern Methods of Controlling Wound Healing after Fistulizin… (10.18008/1816-5095-2017-1-5-11) | Abstract References ORCID License | 84.51 | 6 |
| 18 | MODERN POSSIBILITIES FOR PROPHYLAXIS OF CATARACT PROGRESSIO… (10.18008/1816-5095-2017-2-120-124) | Abstract References ORCID License | 84.51 | 6 |
| 19 | MICROINVASIVE TRANSSCLERAL FIXATION TECHNOLOGY OF THE FOLDAB… (10.18008/1816-5095-2017-4-291-298) | Abstract References ORCID License | 84.51 | 6 |
| 20 | Anisometropia and Anisometropic Amblyopia (Literature Review… (10.18008/1816-5095-2018-1-12-17) | Abstract References ORCID License | 84.51 | 6 |
| 21 | THERAPEUTIC EYELIDS HYGIENE IN THE ALGORITHMS OF PREVENTION… (10.18008/1816-5095-2016-3-205-212) | Abstract References ORCID License | 77.82 | 5 |
| 22 | ALLERGIC EYE DISEASES IN CHILDREN. MODERN VIEW ON PATHOGENE… (10.18008/1816-5095-2017-2-125-129) | Abstract References ORCID License | 77.82 | 5 |
| 23 | INFLUENCE OF NON-STEROIDAL ANTI-INFLAMMATORY EYE DROPS ON TH… (10.18008/1816-5095-2017-3-251-259) | Abstract References ORCID License | 77.82 | 5 |
| 24 | EVOLUTION THE CONCEPTS OF ROLE OF INTRAOCULAR PRESSURE IN GL… (10.18008/1816-5095-2016-3-135-143) | Abstract References ORCID License | 60.21 | 3 |
| 25 | SCREENING METHODS FOR THE HYPOXIC KERATOPATHY EVALUATION IN… (10.18008/1816-5095-2016-3-169-177) | Abstract References ORCID License | 60.21 | 3 |
| 26 | The Role of Low-frequency TRANS-orbital Magnetic Stimulation… (10.18008/1816-5095-2016-4-273-277) | Abstract References ORCID License | 60.21 | 3 |
| 27 | MANAGEMENT OF RESIDUAL REFRACTIVE ERROR AFTER CATARACT PHAC… (10.18008/1816-5095-2017-2-106-112) | Abstract References ORCID License | 60.21 | 3 |
| 28 | MODERN OPPORTUNITIES IN UVEITIS TREATMENT (10.18008/1816-5095-2017-2-113-119) | Abstract References ORCID License | 60.21 | 3 |
| 29 | THE ROLE OF MICROTRAUMA IN THE DEVELOPMENT OF BACTERIAL COR… (10.18008/1816-5095-2017-2-136-140) | Abstract References ORCID License | 60.21 | 3 |
| 30 | MINIMALLY INVASIVE METHODS OF SURGICAL TREATMENT OF ENDOCRIN… (10.18008/1816-5095-2017-2-163-169) | Abstract References ORCID License | 60.21 | 3 |
| 31 | CLINICAL FEATURES, DIAGNOSIS, THE RESULTS OF THERAPEUTIC AND… (10.18008/1816-5095-2017-4-306-314) | Abstract References ORCID License | 60.21 | 3 |
| 32 | Laser Retinotomy with “Ultra Q Reflex” System for the Preven… (10.18008/1816-5095-2018-1-24-31) | Abstract References ORCID License | 60.21 | 3 |
| 33 | Clinical Features of the Ophthalmic Status in Pregnant Women (10.18008/1816-5095-2018-1-5-11) | Abstract References ORCID License | 60.21 | 3 |
| 34 | Мodification of Mechanical Limbal Stem Cell Deficiency Model (10.18008/1816-5095-2018-1-51-57) | Abstract References ORCID License | 60.21 | 3 |
| 35 | Change in the Ophthalmobiometric Parameters in Myopia and Hy… (10.18008/1816-5095-2018-1-58-63) | Abstract References ORCID License | 60.21 | 3 |
| 36 | Clinical Aspects of Using of Etiotropic Immunotherapy in Com… (10.18008/1816-5095-2018-1-80-86) | Abstract References ORCID License | 60.21 | 3 |
| 37 | The Complex Treatment Algorithm for Dry Eye Syndrome with Me… (10.18008/1816-5095-2020-3s-640-647) | Abstract ORCID | 53.96 | 11 |
| 38 | Monitoring of Separate Pathogenetically Significant Biochemi… (10.18008/1816-5095-2018-2-189-199) | ORCID License | 50.00 | 9 |
| 39 | INSTRUMENTAL TREATMENT OF AMBLYOPIA (10.18008/1816-5095-2016-3-144-150) | Abstract References ORCID License | 47.71 | 2 |
| 40 | EFFICACY AND SAFETY OF A NEW COMBINED MEDICATION WITH RECOMB… (10.18008/1816-5095-2016-3-197-204) | Abstract References ORCID License | 47.71 | 2 |
| 41 | Modern Tendencies in the Treatment of Strabismus in Children (10.18008/1816-5095-2016-4-260-264) | Abstract References ORCID License | 47.71 | 2 |
| 42 | Аccommodative Eye System as an Indicator of the Effectivenes… (10.18008/1816-5095-2016-4-278-281) | Abstract References ORCID License | 47.71 | 2 |
| 43 | Management of Residual Refractive Error after Cataract Phaco… (10.18008/1816-5095-2017-1-18-26) | Abstract References ORCID License | 47.71 | 2 |
| 44 | Cytotoxicity Evaluation of Tear Substitutes Using in vitro S… (10.18008/1816-5095-2017-1-59-66) | Abstract References ORCID License | 47.71 | 2 |
| 45 | Treatment of Retinal Separation in HIV-infected Patients wit… (10.18008/1816-5095-2017-1-84-87) | Abstract References ORCID License | 47.71 | 2 |
| 46 | THE SURVIVAL RATE OF PATIENTS FOLLOWING UVEAL MELANOMA EYE… (10.18008/1816-5095-2017-2-170-174) | Abstract References ORCID License | 47.71 | 2 |
| 47 | СLINICAL FEATURES, DIAGNOSIS AND TREATMENT OF PATIENTS WITH… (10.18008/1816-5095-2017-3-233-239) | Abstract References ORCID License | 47.71 | 2 |
| 48 | MONITORING OF FUNCTIONAL PARAMETERS IN THE PATIENTS WITH EAR… (10.18008/1816-5095-2017-3-260-267) | Abstract References ORCID License | 47.71 | 2 |
| 49 | СOMPARATIVE EFFICIENCY OF USE OF METHYLETHYLPYRIDINOL BY THE… (10.18008/1816-5095-2017-3-268-273) | Abstract References ORCID License | 47.71 | 2 |
| 50 | СORNEAL ENDOTHELIUM IN EYES WITH PSEUDOEXFOLIATION SYNDROME… (10.18008/1816-5095-2017-4-347-354) | Abstract References ORCID License | 47.71 | 2 |